Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

about

PPAR Agonists and Metabolic Syndrome: An Established Role?Effect of dietary omega-3 fatty acid supplementation on frailty-related phenotypes in older adults: a systematic review and meta-analysis protocol.

P2860

Q54936265-1F224DF9-392E-4309-8E34-C96E6B3BFAB0 Q55339529-3C8F4356-5407-45DD-988E-E2273B378BB4

P2860

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

Item

http://www.wikidata.org/entity/Q47633216

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@en

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@nl

type

Item

label

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@en

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@nl

prefLabel

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@en

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@nl

P1476

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

@en

P2093

Daniel E Soffer

http://www.w3.org/2001/XMLSchema#string

Frances M Burke

http://www.w3.org/2001/XMLSchema#string

Megan F Burke

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis

Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?

Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance

P2888

s11883-017-0700-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-017-0700-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29116404

http://www.w3.org/2001/XMLSchema#string

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

about

P2860

P2860

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698